lamivudine / Generic mfg.  >>  Phase 2
Welcome,         Profile    Billing    Logout  

8 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lamivudine / Generic mfg.
ACTRN12605000742673: AVX754 (nucleoside reverse transcriptase inhibitor) to treat drug resistant HIV

Recruiting
2
60
 
Avexa Ltd, Avexa Ltd
HIV Infections
 
 
ChiCTR-TRC-11001683: Perioperative hepatitis B virus load control strategies and molecular mechanisms of anti-recurrence and metastasis in hepatic cancer

Completed
2
200
 
Give lamivudine antiviral therapy ;Give lamivudine and foscarnet antiviral therapy ;Give lamivudine and adefovir dipivoxil antiviral therapy ;Give entecavir antiviral therapy
1st Affiliated Hospital of Medical College, Zhejiang University; Zhejiang University School of Medicine, self
hepatic cancer and hepatitis B virus
 
 
PREVENIR-PEV, NCT03869944: Preventing Childhood HIV: Rescue Intervention. ANRS 12388

Active, not recruiting
2
97
RoW
Lamivudine Oral Solution
ANRS, Emerging Infectious Diseases, Institut National de la Santé Et de la Recherche Médicale, France, Centre Muraz
HIV-1
03/22
03/22
DYNAMIC, NCT04900038 / 2021-000016-28: A Clinical Trial of GSK3640254 + Dolutegravir (DTG) in Human Immunodeficiency Virus-1 Infected Treatment-naive Adults

Terminated
2
85
Europe, Canada, US, RoW
GSK3640254, Dolutegravir, Lamivudine capsules, Lamivudine tablets
ViiV Healthcare, Syneos Health
HIV Infections
11/22
05/23
NCT06519357: A Single-center, Self-controlled, Prospective Case Series Pilot Study to Assess the Effect of Lamivudine (3TC) on Neurocognitive Impairment Biomarkers and Type-I IFN (Interferon)-Stimulated Genes in the Plasma of Patients With Mild Cognitive Impairment (MCI)

Not yet recruiting
2
25
Europe
Lamivudine 300 MG
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia, IrsiCaixa
Mild Cognitive Impairment
04/25
06/25
NCT04696575: Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer

Recruiting
2
28
US
Atezolizumab, MPDL 3280A, MPDL 328OA, MPDL-3280A, MPDL3280A, MPDL328OA, RG7446, RO5541267, Tecentriq, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Etoposide, Demethyl Epipodophyllotoxin Ethylidine Glucoside, EPEG, Lastet, Toposar, Vepesid, VP 16, VP 16-213, VP-16, VP-16-213, VP16, Lamivudine, (-)-BCH-189, 3TC, Epivir, GR109714X, LAM
Roswell Park Cancer Institute
Extensive Stage Lung Small Cell Carcinoma
07/25
07/26
ART-AD, NCT04552795: Pilot Study to Investigate the Safety and Feasibility of AntiRetroviral Therapy for Alzheimer's Disease

Completed
1/2
12
US
3TC, Epivir, lamivudine
The University of Texas Health Science Center at San Antonio, Owens Medical Research Foundation
Alzheimer Disease, Early Onset
05/23
11/23
NCT06494579: Lamivudine for Solid Tumors

Not yet recruiting
1/2
24
US
Lamivudine, PD-L1 Blocker
Thomas Marron
Relapsed/Refractory Solid Tumors
07/27
07/27

Download Options